Tag : Issuance

CCT Impact

Sundial Announces Issuance of New Warrants and US$89.1 Million Proceeds from Warrant Exercises

CCT IMPACT Agent
Sundial Growers Inc. (NASDAQ: SNDL) (“Sundial” or the “Company”) announced today that holders (the “Holders”) of 98,333,334 warrants (the “Warrants”) to purchase common shares (the “Common Shares”) of the Company will exercise for cash their Warrants at prices of US$0.80 and US$1.10 for gross proceeds to Sundial of US$89.1 million. In exchange, the Company will issue......
CCT Impact

CannTrust Announces the Issuance of CCAA Representation Order – Appointment of Representative Counsel for the Securities Claimants

CCT IMPACT Agent
CannTrust Holdings Inc. (“CannTrust” or the “Company”) today announced the issuance of a CCAA Representation Order by the Ontario Superior Court of Justice subject to proceedings under Canada’s Companies’ Creditors Arrangement Act (“CCAA“). Today’s order appoints certain representatives to represent the interests of certain Securities Claimants and appoints counsel for them, subject to......
CCT Impact

Cansortium Announces Shares for Debt Settlement and Issuance of Stock Options

CCT IMPACT Agent
Cansortium Inc. (CSE : TIUM.U) (OTCQB : CNTMF) (“Cansortium” or the “Company“), a vertically integrated cannabis company with operations in Florida, Texas, Michigan and Pennsylvania, announces that it has agreed with certain of its directors and officers to issue an aggregate of 1,286,110 common shares (“Debt Shares“) to such directors and officers in exchange for the......
Market Watch

Aphria Announces Issuance of Shares in Respect of Previously Announced Settlement of Claim

CCT IMPACT Agent
Aphria Inc. (“Aphria“) (TSX: APHA andNASDAQ: APHA), a leading global cannabis company, today announced that it has issued 1,658,375 common shares (the “Settlement Shares“) to Emblem Cannabis Corporation (“Emblem“), a wholly owned subsidiary of Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health“) as part of a settlement agreement entered into......
CCT Impact

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has been issued a Notice of Allowance for a patent from the United......